Dániel J. Erdélyi

1.3k total citations
44 papers, 649 citations indexed

About

Dániel J. Erdélyi is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Molecular Biology. According to data from OpenAlex, Dániel J. Erdélyi has authored 44 papers receiving a total of 649 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Public Health, Environmental and Occupational Health, 22 papers in Pediatrics, Perinatology and Child Health and 11 papers in Molecular Biology. Recurrent topics in Dániel J. Erdélyi's work include Acute Lymphoblastic Leukemia research (26 papers), Childhood Cancer Survivors' Quality of Life (17 papers) and Extracellular vesicles in disease (6 papers). Dániel J. Erdélyi is often cited by papers focused on Acute Lymphoblastic Leukemia research (26 papers), Childhood Cancer Survivors' Quality of Life (17 papers) and Extracellular vesicles in disease (6 papers). Dániel J. Erdélyi collaborates with scholars based in Hungary, Austria and Denmark. Dániel J. Erdélyi's co-authors include Gábor Kovács, Ágnes F. Semsei, Csaba Szalai, Márta Hegyi, Katalin Csordás, Judit Müller, András Gézsi, Orsolya Lautner‐Csorba, András Falus and Ildikó Ungvári and has published in prestigious journals such as PLoS ONE, Scientific Reports and British Journal of Haematology.

In The Last Decade

Dániel J. Erdélyi

40 papers receiving 641 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dániel J. Erdélyi Hungary 16 291 242 203 199 99 44 649
Ágnes F. Semsei Hungary 19 227 0.8× 197 0.8× 220 1.1× 316 1.6× 97 1.0× 38 788
Robert O. Bash United States 11 173 0.6× 79 0.3× 240 1.2× 213 1.1× 26 0.3× 15 690
Laura Tuohey Australia 18 153 0.5× 533 2.2× 38 0.2× 180 0.9× 61 0.6× 33 1.0k
Juan Eduardo Megías‐Vericat Spain 16 86 0.3× 49 0.2× 164 0.8× 230 1.2× 32 0.3× 57 654
Mathew J. Edick United States 13 158 0.5× 97 0.4× 96 0.5× 294 1.5× 9 0.1× 25 603
Virginia Davenport United States 12 91 0.3× 61 0.3× 136 0.7× 134 0.7× 40 0.4× 21 639
Milind Ronghe United Kingdom 14 58 0.2× 68 0.3× 170 0.8× 180 0.9× 14 0.1× 24 605
Mark Hamilton United States 9 50 0.2× 51 0.2× 147 0.7× 194 1.0× 60 0.6× 26 560
John Hayslip United States 14 178 0.6× 57 0.2× 164 0.8× 510 2.6× 12 0.1× 29 962
Venkateshwari Ananthapur India 15 38 0.1× 66 0.3× 92 0.5× 154 0.8× 63 0.6× 73 547

Countries citing papers authored by Dániel J. Erdélyi

Since Specialization
Citations

This map shows the geographic impact of Dániel J. Erdélyi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dániel J. Erdélyi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dániel J. Erdélyi more than expected).

Fields of papers citing papers by Dániel J. Erdélyi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dániel J. Erdélyi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dániel J. Erdélyi. The network helps show where Dániel J. Erdélyi may publish in the future.

Co-authorship network of co-authors of Dániel J. Erdélyi

This figure shows the co-authorship network connecting the top 25 collaborators of Dániel J. Erdélyi. A scholar is included among the top collaborators of Dániel J. Erdélyi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dániel J. Erdélyi. Dániel J. Erdélyi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Szepesi, Ágota, et al.. (2024). The significance of CD49f expression in pediatric B-cell acute lymphoblastic leukemia. American Journal of Clinical Pathology. 163(2). 169–177.
2.
Székely, Gábor J., Vera Goda, Krisztián Kállay, et al.. (2023). Chromosomal breakage tests in the differential diagnosis of Fanconi anemia and aplastic anemia. European Journal Of Haematology. 111(2). 254–262. 2 indexed citations
3.
Müller, Judit, et al.. (2023). Our Experiences with Asparaginase Activity Measurements in Children with Lymphoblastic Diseases. Children. 10(7). 1160–1160. 5 indexed citations
4.
Erdélyi, Dániel J., et al.. (2023). A termékenység megőrzése céljából gyermekkorban végzett petefészekszövet-fagyasztás első hazai esete. Orvosi Hetilap. 164(3). 104–109. 2 indexed citations
5.
Erdélyi, Dániel J., et al.. (2022). Potential role of MAP2K1 mutation in the trans-differentiation of interdigitating dendritic cell sarcoma: Case report and literature review. Frontiers in Pediatrics. 10. 959307–959307. 1 indexed citations
6.
Jakab, Zsuzsanna, Miklós Garami, Monika Csóka, et al.. (2020). Late mortality in survivors of childhood cancer in Hungary. Scientific Reports. 10(1). 10761–10761. 4 indexed citations
7.
Budai, Barna, et al.. (2020). GSTM1 null and GSTT1 null: predictors of cisplatin-caused acute ototoxicity measured by DPOAEs. Journal of Molecular Medicine. 98(7). 963–971. 9 indexed citations
8.
Farkas, Tamás, Judit Müller, Dániel J. Erdélyi, Monika Csóka, & Gábor Kovács. (2017). Absolute Lymphocyte Count (ALC) after Induction Treatment Predicts Survival of Pediatric Patients with Acute Lymphoblastic Leukemia. Pathology & Oncology Research. 23(4). 889–897. 5 indexed citations
9.
Semsei, Ágnes F., András Gézsi, Katalin Csordás, et al.. (2015). Subgroups of Paediatric Acute Lymphoblastic Leukaemia Might Differ Significantly in Genetic Predisposition to Asparaginase Hypersensitivity. PLoS ONE. 10(10). e0140136–e0140136. 14 indexed citations
10.
Gézsi, András, Orsolya Lautner‐Csorba, Dániel J. Erdélyi, et al.. (2014). In interaction with gender a common CYP3A4 polymorphism may influence the survival rate of chemotherapy for childhood acute lymphoblastic leukemia. The Pharmacogenomics Journal. 15(3). 241–247. 9 indexed citations
11.
Németh, Krisztína, Dóra Török, Katalin Csordás, et al.. (2013). The glucocorticoid receptor gene polymorphism N363S predisposes to more severe toxic side effects during pediatric acute lymphoblastic leukemia (ALL) therapy. International Journal of Hematology. 97(2). 216–222. 19 indexed citations
12.
Müller, Judit, et al.. (2013). Examination of late pulmonary toxicity in children treated for malignancies. Orvosi Hetilap. 154(9). 345–350.
13.
Lautner‐Csorba, Orsolya, András Gézsi, Ágnes F. Semsei, et al.. (2012). Candidate gene association study in pediatric acute lymphoblastic leukemia evaluated by Bayesian network based Bayesian multilevel analysis of relevance. BMC Medical Genomics. 5(1). 42–42. 36 indexed citations
14.
Hegyi, Márta, Katalin Csordás, Dániel J. Erdélyi, et al.. (2012). Clinical relations of methotrexate pharmacokinetics in the treatment for pediatric osteosarcoma. Journal of Cancer Research and Clinical Oncology. 138(10). 1697–1702. 24 indexed citations
15.
Csordás, Katalin, et al.. (2012). Comparison of pharmacokinetics and toxicity after high-dose methotrexate treatments in children with acute lymphoblastic leukemia. Anti-Cancer Drugs. 24(2). 189–197. 51 indexed citations
16.
Erdélyi, Dániel J., Martin Elliott, & Bob Phillips. (2011). Urine catecholamines in paediatrics. Archives of Disease in Childhood Education & Practice. 96(3). 107–111. 14 indexed citations
17.
Semsei, Ágnes F., Dániel J. Erdélyi, Ildikó Ungvári, et al.. (2011). ABCC1 polymorphisms in anthracycline‐induced cardiotoxicity in childhood acute lymphoblastic leukaemia. Cell Biology International. 36(1). 79–86. 93 indexed citations
18.
Semsei, Ágnes F., Dániel J. Erdélyi, Ildikó Ungvári, et al.. (2008). Association of some rare haplotypes and genotype combinations in the MDR1 gene with childhood acute lymphoblastic leukaemia. Leukemia Research. 32(8). 1214–1220. 36 indexed citations
19.
Kovács, Gábor, Monika Csóka, Andrea Ponyi, et al.. (2008). Late Immune Recovery in Children Treated for Malignant Diseases. Pathology & Oncology Research. 14(4). 391–397. 17 indexed citations
20.
Kovács, Gábor, et al.. (2006). Subacute cardiotoxicity caused by anthracycline therapy in children: can dexrazoxane prevent this effect?. European Journal of Pediatrics. 166(11). 1187–1188. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ágnes F. Semsei Breakdown of academic impact, for papers by Robert O. Bash Breakdown of academic impact, for papers by Laura Tuohey Breakdown of academic impact, for papers by Juan Eduardo Megías‐Vericat Breakdown of academic impact, for papers by Mathew J. Edick Breakdown of academic impact, for papers by Virginia Davenport Breakdown of academic impact, for papers by Milind Ronghe Breakdown of academic impact, for papers by Mark Hamilton Breakdown of academic impact, for papers by John Hayslip Breakdown of academic impact, for papers by Venkateshwari Ananthapur
Rankless by CCL
2026